Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice
Authors:
- 9 December 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (24) , 5419-5422
Abstract
Inherited hematologic defects that lack an in vivo selective advantage following gene correction may benefit from effective yet minimally toxic cytoreduction of endogenous hematopoietic stem cells (HSCs) prior to transplantation of gene-modified HSCs. We studied the efficacy of administering a novel sequential treatment of parenteral ACK2, an antibody that blocks KIT, followed by low-dose irradiation (LD-IR) for conditioning of wild-type and X-linked chronic granulomatous disease (X-CGD) mice. In wild-type mice, combining ACK2 and LD-IR profoundly decreased endogenous competitive long-term HSC repopulating activity, and permitted efficient and durable donor-derived HSC engraftment after congenic transplantation. ACK2 alone was ineffective. The combination of ACK2 and LD-IR was also effective conditioning in X-CGD mice for engraftment of X-CGD donor HSCs transduced ex vivo with a lentiviral vector. We conclude that combining ACK2 with LD-IR is a promising approach to effectively deplete endogenous HSCs and facilitate engraftment of transplanted donor HSCs.Keywords
This publication has 14 references indexed in Scilit:
- A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activityBlood, 2009
- Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling PathwayClinical Cancer Research, 2008
- Efficient Transplantation via Antibody-Based Clearance of Hematopoietic Stem Cell NichesScience, 2007
- Granulocyte Colony-Stimulating Factor Prior to Nonmyeloablative Irradiation Decreases Murine Host Hematopoietic Stem Cell Function and Increases Engraftment of Donor Marrow CellsStem Cells, 2007
- Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiencyCurrent Opinion in Hematology, 2007
- Chronic Granulomatous Disease and Other Disorders of Phagocyte FunctionHematology-American Society Hematology Education Program, 2005
- Gene therapy for chronic granulomatous diseaseExpert Opinion on Biological Therapy, 2004
- Donor chimerism and stem cell function in a murine congenic transplantation model after low-dose radiation conditioningExperimental Hematology, 2002
- Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide productionNature Genetics, 1995
- Expression and function of c-kit in hemopoietic progenitor cells.Journal of Experimental Medicine, 1991